Telomerase levels in schizophrenia: a preliminary study

Schizophr Res. 2008 Dec;106(2-3):242-7. doi: 10.1016/j.schres.2008.08.028. Epub 2008 Oct 1.

Abstract

We previously demonstrated that telomere length was markedly reduced in peripheral blood lymphocytes from individuals with schizophrenia. Since reduced telomere length can be caused by decreased telomerase activity, we quantitated basal telomerase activity in peripheral blood lymphocytes derived from individuals with schizophrenia (n=53), unaffected relatives (n=31) and unrelated controls (n=59). Telomerase activity varied greatly among individuals, suggesting that this enzymatic activity is affected by various factors. We observed a nominally significant decrease in telomerase activity among individuals with schizophrenia compared to unaffected individuals (unaffected relatives and unrelated controls). Further studies are needed to investigate the role of telomerase in schizophrenia.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / pharmacology
  • Cohort Studies
  • Family
  • Female
  • Humans
  • Lymphocytes / drug effects
  • Lymphocytes / enzymology
  • Male
  • Polymerase Chain Reaction
  • Schizophrenia / blood
  • Schizophrenia / enzymology*
  • Telomerase / blood*
  • Telomerase / drug effects
  • Telomerase / genetics
  • Telomere / drug effects
  • Telomere / metabolism

Substances

  • Antipsychotic Agents
  • Telomerase